University of British Columbia
Development of a CRISPR gene correction strategy for aniridia employing a minimally humanized mouse embryonic stem cell-based disease model
Abstract
dc:descriptionAniridia is a rare congenital blindness caused by heterozygous variants in the PAX6 gene. There is no vision-saving therapy, but one exciting approach is the gene editing capabilities of CRISPR systems to permanently correct the genomic variants. Pre-clinical studies to develop such a therapy in animal models face the challenge of showing efficacy when binding human DNA. To answer this challenge, while developing a CRISPR therapy for aniridia, we proposed the “CRISPR Humanized Minimally Mouse Models” (CHuMMMs) strategy. I hypothesize that a CRISPR gene strategy can be developed and optimized in humanized mouse embryonic stem cells that will be able to distinguish between the patient variant and non-variant chromosomes, laying the foundation for correcting aniridic congenital blindness in humans. Thus, we minimally humanized Pax6 exon 9, the location of the most common aniridia variant c.718C>T, creating a 312 bp “landing pad” of human DNA. Initially, we generated a non-variant mouse to show humanization did not disrupt Pax6 function. Then, we generated a CHuMMMs cell-based disease model, in which we tested five CRISPR enzymes for efficacy. In this system, base editor ABE8e had the highest correction of the variant at 76.8%. Finally, we used LNPs to deliver ABE8e to primary neurons ex vivo, which altered a second patient variant and rescued 24.8% Pax6 expression. Thus, we demonstrated the CHuMMMs approach, and showed the first genomic editing by ABE8e encapsulated as an LNP-RNP. Furthermore, we laid the foundation for translation of the proposed CRISPR therapy to human cells and eventually aniridia patients.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Medical Genetics
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Adair, Bethany
- Contributors dc:contributor
-
- Simpson, Elizabeth M.
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/84969